ranolazine has been researched along with Hibernation, Myocardial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lango, R | 1 |
| Hale, SL; Kloner, RA | 1 |
1 review(s) available for ranolazine and Hibernation, Myocardial
| Article | Year |
|---|---|
[Regulation of myocardial metabolism: possibilities and application in cardiac surgery].
Topics: Acetanilides; Animals; Cardiac Surgical Procedures; Cardiotonic Agents; Carnitine; Drug Therapy, Combination; Glucose; Glutamine; Humans; Insulin; Intraoperative Care; Myocardial Stunning; Myocardium; Myocytes, Cardiac; Piperazines; Potassium; Ranolazine; Trimetazidine; Vasodilator Agents | 2003 |
1 other study(ies) available for ranolazine and Hibernation, Myocardial
| Article | Year |
|---|---|
Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
Topics: Acetanilides; Animals; Blood Pressure; Disease Models, Animal; Heart Rate; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardial Stunning; Piperazines; Rabbits; Random Allocation; Ranolazine; Sodium Channel Blockers; Stroke Volume; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2006 |